If you are comparing omeprazole and esomeprazole, side effects and safety are important factors to consider alongside cost and dosing. Both medicines are proton pump inhibitors (PPIs). Esomeprazole is the S isomer of omeprazole, and both work by reducing stomach acid production through the same mechanism.
Their side effect profiles are broadly similar, but there are some important safety considerations, particularly around medicine interactions. This guide explains the known short term side effects, longer term considerations, and interactions with other common medicines, including their use for gastro oesophageal reflux disease (GORD) and other acid related conditions, based on guidance from sources such as MHRA, NICE, and NHS.
Treatment suitability depends on an individual clinical assessment. This guide provides general information only and is not a substitute for advice from your prescriber, who will consider your medical history and current medicines before recommending treatment.
If you are comparing omeprazole and esomeprazole and want to understand how their side effects differ, both medicines have similar short term side effect profiles because they work in the same way. Commonly reported side effects may include headache, nausea, diarrhoea, abdominal pain, reflux symptoms, and heartburn, and are often mild.
Medicine interactions are an important consideration. Current MHRA guidance advises that omeprazole and esomeprazole should generally be avoided with clopidogrel, as they may reduce its effectiveness. If you take clopidogrel, your prescriber may consider alternatives such as pantoprazole or lansoprazole, depending on your individual circumstances.
Long term use of proton pump inhibitors has been associated with potential risks, including reduced magnesium and vitamin B12 levels, and an increased risk of fractures with prolonged use, particularly at higher doses. This is why ongoing treatment is usually reviewed periodically by a healthcare professional.
EverydayMeds' online consultation is reviewed by a UK registered prescriber, who will assess whether treatment is appropriate based on your individual health needs.
Common Short-Term Side Effects
Because omeprazole and esomeprazole work on the same target, the proton pump in the stomach's acid producing cells, they have a similar short term side effect profile.
Commonly reported side effects for both medicines may include:
- Headache
- Nausea
- Diarrhoea or constipation
- Abdominal pain
- Flatulence
These effects are usually mild and may improve as your body adjusts to treatment, particularly during the first few weeks. If side effects are persistent, troublesome, or affecting your daily life, speak to your prescriber or pharmacist for advice rather than stopping treatment without guidance.
Proton Pump Drug Interactions: What's Actually Different
This is one of the areas where the two medicines have important similarities, and where accurate information matters.
Clopidogrel: Clopidogrel is an antiplatelet medicine that needs to be activated in the body by the CYP2C19 liver enzyme. Omeprazole and esomeprazole can both inhibit this enzyme, which may reduce how effectively clopidogrel is activated. Current MHRA and European Medicines Agency guidance advises avoiding the combination of clopidogrel with omeprazole or esomeprazole unless there is a clear clinical reason to use them together.
In this situation, omeprazole and esomeprazole are considered similar and neither is regarded as the safer option. PPIs such as pantoprazole, lansoprazole, and rabeprazole are generally considered to have a lower interaction risk with clopidogrel and may be considered where a PPI is needed, based on medical advice.
Warfarin and digoxin: Both omeprazole and esomeprazole may affect how some medicines, including warfarin and digoxin, work in the body. If you take these medicines alongside a PPI, your healthcare professional may recommend appropriate monitoring.
Other medicines affected by CYP2C19: Because both medicines affect the same liver enzyme pathway, they may interact with other medicines that are processed in this way. Always provide your full medication list, including prescription medicines, over the counter medicines, and supplements, during your consultation so your prescriber can assess suitability.
Long-Term Safety Considerations in Erosive Esophagitis
Long term PPI use: Long term use of proton pump inhibitors (PPIs) carries some recognised considerations that apply to omeprazole and esomeprazole as a medicine class, rather than one medicine specifically.
Bone fracture risk: Long term use of higher dose PPIs has been associated with a modest increase in fracture risk, particularly involving the hip, wrist, and spine. This may be linked to changes in calcium absorption.
Magnesium and vitamin B12 levels: Extended use of PPIs has been linked to lower magnesium levels (hypomagnesaemia) and reduced vitamin B12 levels. Product safety information recognises that low magnesium levels can occur after prolonged treatment, which is one reason regular review may be recommended for people receiving long term PPI treatment.
Kidney effects: Rare cases of kidney problems, including acute interstitial nephritis, have been reported with PPI use. This is uncommon but is a consideration when reviewing long term treatment.
Gut infection risk: By reducing stomach acid, PPIs may slightly increase the risk of certain gut infections, including C. difficile associated diarrhoea, particularly in some higher risk settings such as hospitals or care environments.
Because of these considerations, NICE guidance recommends that long term PPI treatment is reviewed periodically and that treatment is adjusted to the lowest effective dose where appropriate. If treatment continues beyond a year, regular review can help confirm that the medicine is still needed and that the dose remains suitable.
Some people may also experience side effects such as dizziness or blurred vision. Speak to your prescriber if these affect your daily activities or safety.
A note on cardiovascular risk and cognitive effects: Some observational studies have explored possible links between long term PPI use and cardiovascular events or cognitive decline. However, the evidence is mixed and does not currently prove that PPIs cause these outcomes. Other factors may influence these findings, so these associations should not be considered established risks.
Pregnancy and Breastfeeding
Omeprazole has been used for longer in clinical practice during pregnancy than esomeprazole, largely because it has been available for a longer period. Current guidance reflects that healthcare professionals have more experience using omeprazole when a proton pump inhibitor (PPI) is considered necessary during pregnancy.
Both medicines can pass into breast milk in small amounts. Whether omeprazole or esomeprazole is appropriate during pregnancy or breastfeeding depends on your individual circumstances and should be discussed with your prescriber.
This information is for general guidance only and should not be used to decide whether to start, stop, or change treatment during pregnancy or breastfeeding.
Clinical and regulatory review note: Confirm current product information and SPC wording before publication.
Special Population Considerations
Older adults may be more susceptible to some of the risks associated with long term PPI use. In some cases, a lower starting dose may be considered, but this is a decision for your prescriber based on your individual health needs and circumstances.
Losec MUPS is a dispersible formulation of omeprazole that may be an option for people who find standard capsules difficult to swallow.
Stopping Treatment
Stopping a proton pump inhibitor (PPI) suddenly after prolonged use may sometimes cause a temporary increase in stomach acid production, known as rebound acid secretion.
Some people notice changes in symptoms within a few days, although the full effect of treatment changes may take longer to assess. If you are considering stopping or changing your PPI, speak to your prescriber, who can advise whether a gradual dose reduction, switch, or another approach is appropriate for your situation.
When to Seek Urgent Medical Advice
Contact a doctor promptly, rather than waiting for a routine review, if you experience:
- Difficulty or pain when swallowing
- Unexplained weight loss alongside reflux symptoms
- Persistent vomiting or vomiting blood
- Black, tarry stools or blood in your stool
- Severe or worsening abdominal pain
These symptoms may indicate other conditions affecting the oesophagus or stomach and may require further investigation beyond routine PPI treatment.
Omeprazole vs Esomeprazole: Safety Snapshot
| Omeprazole | Esomeprazole | |
|---|---|---|
| Common short-term side effects | Headache, nausea, diarrhoea, abdominal pain | Same profile — headache, nausea, diarrhoea, abdominal pain |
| Clopidogrel interaction | Advised against by MHRA/EMA unless essential | Advised against by MHRA/EMA unless essential — same guidance as omeprazole |
| Lower-interaction alternatives (if on clopidogrel) | Lansoprazole, pantoprazole, rabeprazole | Lansoprazole, pantoprazole, rabeprazole |
| Long-term risks | Fracture risk, low magnesium/B12, rare kidney effects | Same class-wide risks |
| Pregnancy | More established usage history | Less established usage history |
| Dispersible option | Yes — Losec MUPS | No |
Choosing Between Omeprazole and Esomeprazole: Quick Takeaways
- Similar safety profile: Side effects are broadly comparable between omeprazole and esomeprazole. There is no established overall safety advantage of one over the other for most people. Some studies have reported differences in symptom control, but individual response varies.
- Clopidogrel interaction: The interaction with clopidogrel applies to both medicines. If you take clopidogrel, discuss this with your prescriber rather than assuming one option is safer. Your prescriber can review your medicines and consider suitable alternatives if needed.
- Long term risks: Potential long term risks are associated with the PPI class rather than one specific medicine. Regular review helps ensure treatment remains appropriate and that the lowest effective dose is used where suitable.
- Individual assessment matters: Pregnancy, complex medical histories, and other medicines require individual clinical assessment. This guide cannot determine which option is right for you.
- Efficacy considerations: Some studies have reported improved healing rates or symptom control with esomeprazole compared with omeprazole in certain GERD populations, particularly at different doses. However, results vary between individuals, and your prescriber will consider your symptoms, treatment history, and overall health when recommending an option.
A prescriber will make the final treatment decision based on your medical history, current medicines, and individual response to treatment.
Other Options If Proton Pump Inhibitors Aren't Suitable
If interactions, side effects, or other clinical factors mean a PPI is not the right option, EverydayMeds also offers other treatments that may be considered alongside lifestyle changes and dietary adjustments:
- Lansoprazole and pantoprazole: PPIs that are generally considered to have a lower interaction risk with clopidogrel compared with omeprazole and esomeprazole.
- Rabeprazole: Another PPI that may be considered when a lower interaction risk option is needed.
- Famotidine: An H2 receptor antagonist that works differently from PPIs and may be considered in some situations where a PPI is not suitable.
Your prescriber will assess your symptoms, medical history, current medicines, and treatment goals before recommending the most appropriate option.
How to Get Treatment Through EverydayMeds
EverydayMeds' online consultation asks about your symptoms, medical history, and current medicines, including any information that may be relevant to medicine interactions.
A registered prescriber reviews your answers and confirms whether treatment, and which medicine, is appropriate for you based on your individual circumstances.
Once approved, orders are dispatched via tracked delivery in discreet packaging. Delivery times vary depending on the treatment and location.
